Symbol
SGMT on Nasdaq
Investment type
Equity / Series A Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned
1,504,642 shares
Security Ownership %
4.9%

AP11 Limited ownership in Sagimet Biosciences Inc. Series A Common Stock, $0.0001 par value per share (SGMT)

24 Jun 2025 - AP11 Limited has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,504,642 shares of Sagimet Biosciences Inc. Series A Common Stock, $0.0001 par value per share (SGMT). This represents 4.9% ownership of the company. In their previous filing dated 20 May 2025, AP11 Ltd had reported owning 1,654,701 shares, indicating a decrease of +9.1%. .